Related references
Note: Only part of the references are listed.Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the ChinaPCa consortium
Meilin Wang et al.
CARCINOGENESIS (2012)
IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility
Hai Ha Nguyen et al.
HUMAN MOLECULAR GENETICS (2012)
Systematic evaluation of bladder cancer risk-associated single-nucleotide polymorphisms in a chinese population
Zhicheng Ma et al.
MOLECULAR CARCINOGENESIS (2012)
Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men
Fang Liu et al.
CANCER SCIENCE (2011)
Genome-wide association study identifies new prostate cancer susceptibility loci
Fredrick R. Schumacher et al.
HUMAN MOLECULAR GENETICS (2011)
Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21
Christopher A. Haiman et al.
NATURE GENETICS (2011)
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study
Zsofia Kote-Jarai et al.
NATURE GENETICS (2011)
Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population
Ryo Takata et al.
NATURE GENETICS (2010)
Effect of Dutasteride on the Risk of Prostate Cancer.
Gerald L. Andriole et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Is There Evidence of a Relationship between Benign Prostatic Hyperplasia and Prostate Cancer? Findings of a Literature Review
Antonio Alcaraz et al.
EUROPEAN UROLOGY (2009)
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
Rosalind A. Eeles et al.
NATURE GENETICS (2009)
Epidemiology of benign prostatic hyperplasia and comorbidities in racial and ethnic minority populations
Gerald P. Hoke et al.
AMERICAN JOURNAL OF MEDICINE (2008)
The rationale for inhibiting 5 alpha-reductase isoenzymes in the prevention and treatment of prostate cancer
Donald J. Tindall et al.
JOURNAL OF UROLOGY (2008)
GPRC6A Null Mice Exhibit Osteopenia, Feminization and Metabolic Syndrome
Min Pi et al.
PLOS ONE (2008)
Looking back at PCPT: Looking forward to new paradigms in prostate cancer screening and prevention
Edith Canby-Hagino et al.
EUROPEAN UROLOGY (2007)
The influence of chronic inflammation in prostatic carcinogenesis: A 5-year followup study
Gregory T. MacLennan et al.
JOURNAL OF UROLOGY (2006)
Associations between polymorphisms in the steroid 5-α reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer
MT Salam et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2005)
Polymorphisms in the 5α reductase type 2 gene and urologic measures of BPH
RO Roberts et al.
PROSTATE (2005)
Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor
P Wellendorph et al.
GENE (2004)
The role of dihydrotestosterone in benign prostatic hyperplasia
C Carson et al.
UROLOGY (2003)
Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: A retrospective analysis
F Di Silverio et al.
EUROPEAN UROLOGY (2003)
Androgen receptor CAG polymorphism and prostate cancer risk
N Mononen et al.
HUMAN GENETICS (2002)
Share Paper
